Namibia vs Thailand: HIV/AIDS deaths averted by antiretroviral therapy
Namibia
11,508 deaths
in 2024
Thailand
10,666 deaths
in 2024
Namibia rank
22nd
Thailand rank
23rd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Namibia
- Thailand
How they compare
Namibia currently reports 11,508 deaths against 10,666 deaths in Thailand, a difference of 842 deaths.
That makes Namibia's figure about 1.1 times Thailand's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Thailand ahead.
Namibia ranks 22nd and Thailand ranks 23rd of 157 countries.
Thailand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Namibia | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 2.7 deaths | 2.7 deaths | Thailand |
| 2000s | 3,179 deaths | 13,768 deaths | 10,589 deaths | Thailand |
| 2010s | 10,813 deaths | 21,782 deaths | 10,969 deaths | Thailand |
| 2020s | 11,415 deaths | 12,351 deaths | 936.42 deaths | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Namibia or Thailand?
- Namibia, at 11,508 deaths against 10,666 deaths in Thailand as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Namibia and Thailand?
- 842 deaths, with Namibia ahead.
- How many years of comparable data are there for Namibia and Thailand?
- 35 years are reported by both, from 1990 to 2024.
- How do Namibia and Thailand rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Namibia ranks 22nd and Thailand ranks 23rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.